Fleischmann R, et al. A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib to Placebo and to Adalimumab, in Patients with Active Rheumatoid Arthritis with Inadequate Response to Methotrexate. ACR 2018, abstract 890.
Interferon-induceerbare proteïnescore voorspelt respons bij SSc-ILD
dec 2020 | ILD, Sclerodermie